As of 2026-05-14, the Intrinsic Value of Akero Therapeutics Inc (AKRO) is -17.80 USD. This AKRO valuation is based on the model Peter Lynch Fair Value. With the current market price of 54.65 USD, the upside of Akero Therapeutics Inc is -132.57%.
Based on its market price of 54.65 USD and our intrinsic valuation, Akero Therapeutics Inc (AKRO) is overvalued by 132.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.80 - -17.80 | -17.80 | -132.57% |
| P/E | (67.29) - (77.90) | (73.87) | -235.2% |
| DDM - Stable | (35.13) - (178.09) | (106.61) | -295.1% |
| DDM - Multi | (0.50) - (1.91) | (0.79) | -101.4% |
| Market Cap (mil) | 4,498.79 |
| Beta | 0.13 |
| Outstanding shares (mil) | 82.32 |
| Enterprise Value (mil) | 4,322.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.45% |
| Cost of Debt | 5.00% |
| WACC | 8.41% |